Navigation Links
GlaxoSmithKline To Cultivate Non-Smoking Environment

GlaxoSmithKline is putting its best foot forward in completing its social responsibility. The steps will also enable the company promote Zyban, its anti-smoking drug. Glaxo is aiding companies cultivate a non-smoking environment as part of its policy, along with providing teams to help in the transition. //

Some of the corporate, which have negotiated for this 'no-smoking' environment, are Housing Development Finance Corporation, the Godrej group, Bharat Petroleum Corporation Ltd., Siemens, Tata Power and The Associated Cement Companies.

The Company is providing for on-line registration for Indian corporate interested in promoting no-smoking culture among its employees. In a step-by-step process, Glaxo is charting out a detailed programme for the employees. The team comprises a doctor and a counsellor. It also includes free education programmes and counselling sessions and Zyban at discounted prices.

Glaxo has also been conducting smoking cessation camps all over Mumbai. Glaxo has also set up a helpline in order to quit smoking. Glaxo had targeted 50,000 patients for its first year with Zyban. It has already crossed the target of 10,000 patients. It had also sponsored the academic grant for the global initiative for obstructive lung disease in order to promote educating the public for chronic obstructive pulmonary disease at the National Conference on pulmonary diseases.

Currently, the drug is priced at Rs. 40 for a 150-mg tablet. The dosage is once a day for the first three days and from the fourth day, two tablets for seven weeks.
'"/>




Page: 1

Related medicine news :

1. GlaxoSmithKline - Changes Lamictal(R) Label Appearance and Packaging
2. GlaxoSmithKline to Supply United States with 8 Million flu vaccine, Fluarix
3. FDA Mislead On Asthma Drug By GlaxoSmithKline
4. GlaxoSmithKline Defends Its Products
5. GlaxoSmithKline launches diabetes and cancer drugs
6. Generic Products Compete With GlaxoSmithKline
7. GlaxoSmithKline Agrees To Settle Paxil Claims For $14 million
8. GlaxoSmithKlines Zofran Helps In Treatment Of Dehydration In Children
9. GlaxoSmithKline’s Epilepsy Drug given the Green Signal by FD
10. GlaxoSmithKline’s Tykerb is to Be Started Earlier in Breast Cancer, Study Find
11. GlaxoSmithKline Signs Outsourcing Deal With TCS
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/20/2017)... ... September 20, 2017 , ... ... a voice for people who have kidney disease. The theme “Describe a positive ... their stories. Entrants needed to meet only one qualification— to have been ...
(Date:9/20/2017)... D.C. (PRWEB) , ... September 20, 2017 , ... ... join the roster of exhibitors at the East-coast edition of MarTech: The Marketing ... MarTech Boston will bring together more than 40 speakers — representing such ...
(Date:9/20/2017)... ... September 20, 2017 , ... Each year ... the National Athletic Trainers’ Association Annual Clinical Symposium and Expo. New research is ... also when Athletic Trainers are acknowledged by their peers with accolades and highly ...
(Date:9/20/2017)... ... ... The Centers for Medicare and Medicaid Services (CMS) stated in the Inpatient Prospective ... S-10 to distribute Disproportionate Share Hospital (DSH) Uncompensated Care Payments over the next two ... October 17, 2017 at 2 P.M. EST and uncover how you can prepare for ...
(Date:9/20/2017)... ... ... “The Trials I Face to Receive God’s Grace”: a mesmerizing take on ... to better one’s life through God. “The Trials I Face to Receive God’s Grace” ... places, found a love for writing. Green feels that expressing his feelings through prayer ...
Breaking Medicine News(10 mins):
(Date:9/9/2017)... Dealmed Medical Supplies, New York ... supplies, drugs, vaccines, and specialty medical products and services, ... to acquire Vantage Medical Supplies, a major distributor of ... New York . ... medical practices, will operate under the Dealmed name as ...
(Date:9/7/2017)... Caris Life Sciences, a leading innovator ... of precision medicine, today announced results from two ... molecular profiling approach in guiding therapeutic strategies in ... (CGP+) with Caris Molecular Intelligence ® to ... level, leading to more therapeutic options and improved ...
(Date:9/6/2017)... -- Robert G. Szewc, M.D., is recognized by Continental Who,s ... his contributions to the Medical field.      ... practice of Kidney and Hypertension Specialists, which specializes in ... He has worked in this position since 2002, and ... as expertise in kidneys, hypertension, chronic disease and anemia, ...
Breaking Medicine Technology: